A Better Way to Screen for Prostate Cancer

Share this content:

Novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinical significant prostate cancer. John Schieszer has the story in today's Medical Minute.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters